George Farmer
Stock Analyst at Scotiabank
(1.84)
# 3,115
Out of 4,876 analysts
75
Total ratings
30.95%
Success rate
-4.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $13.11 | +258.50% | 1 | Jun 13, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $133 → $93 | $64.77 | +43.58% | 2 | May 9, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $9.29 | +82.99% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $2.98 | +302.68% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $7.09 | +26.94% | 4 | Apr 10, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Sector Outperform | $3.15 → $1.4 | $0.24 | +478.03% | 2 | Mar 21, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $23.52 | +74.32% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $18.45 | +181.84% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $54.10 | +47.87% | 8 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Sector Outperform | $244 → $224 | $126.92 | +76.49% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $28.17 | +262.09% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $14 → $12 | $9.28 | +29.31% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $22 → $23 | $6.28 | +266.24% | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $5.73 | +74.52% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $560.04 | +27.67% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $6.29 | +265.66% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $4.25 | +370.59% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $21 → $41 | $1.99 | +1,960.30% | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $33.48 | +127.00% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.71 | +379.70% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $27.54 | +295.79% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $70.81 | +22.86% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $1.52 | +2,071.05% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.71 | +5,530.63% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $43.09 | -37.34% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $128.15 | -41.47% | 3 | Apr 29, 2020 |
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $13.11
Upside: +258.50%
Arcellx
May 9, 2025
Maintains: Sector Outperform
Price Target: $133 → $93
Current: $64.77
Upside: +43.58%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $9.29
Upside: +82.99%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $2.98
Upside: +302.68%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $7.09
Upside: +26.94%
Adaptimmune Therapeutics
Mar 21, 2025
Maintains: Sector Outperform
Price Target: $3.15 → $1.4
Current: $0.24
Upside: +478.03%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $23.52
Upside: +74.32%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $18.45
Upside: +181.84%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $54.10
Upside: +47.87%
Biogen
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $126.92
Upside: +76.49%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $28.17
Upside: +262.09%
Feb 12, 2025
Maintains: Sector Outperform
Price Target: $14 → $12
Current: $9.28
Upside: +29.31%
Feb 11, 2025
Maintains: Sector Outperform
Price Target: $22 → $23
Current: $6.28
Upside: +266.24%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $5.73
Upside: +74.52%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $560.04
Upside: +27.67%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $6.29
Upside: +265.66%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $4.25
Upside: +370.59%
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $1.99
Upside: +1,960.30%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $33.48
Upside: +127.00%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.71
Upside: +379.70%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $27.54
Upside: +295.79%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $70.81
Upside: +22.86%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $1.52
Upside: +2,071.05%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.71
Upside: +5,530.63%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $43.09
Upside: -37.34%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $128.15
Upside: -41.47%